Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family. / Tufail, Soban; Shah, Majid Ali; Zafar, Maryam; Asif, Tayyab Ali; Shehzad, Aamir; Shah, Muhammad Salahuddin; Habib, Mudasser; Saleemi, Muhammad Kashif; Muddassar, Muhammad; Mirza, Osman; Iqbal, Mazhar; Rahman, Moazur.
In: Vaccine, Vol. 39, No. 27, 2021, p. 3560-3564.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family
AU - Tufail, Soban
AU - Shah, Majid Ali
AU - Zafar, Maryam
AU - Asif, Tayyab Ali
AU - Shehzad, Aamir
AU - Shah, Muhammad Salahuddin
AU - Habib, Mudasser
AU - Saleemi, Muhammad Kashif
AU - Muddassar, Muhammad
AU - Mirza, Osman
AU - Iqbal, Mazhar
AU - Rahman, Moazur
N1 - Copyright © 2021 Elsevier Ltd. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Adenoviruses cause economically important diseases in vertebrates. Effective vaccines against adenoviral diseases are currently lacking. Here, we report a highly conserved epitopic region on hexon proteins of adenoviruses that generate a strong immune response when used as a virus-like-particle (VLP) vaccine, produced by inserting the epitopic region into the core protein of hepatitis B virus. For evaluation of its protective efficacy, the epitopic region from a representative adenovirus, fowl adenovirus serotype 4 (FAdV-4), was tested as a VLP vaccine which conferred 90% protection against challenge with a virulent FAdV-4 isolate in chickens. Importantly, such a high level of protection is not achieved when the epitopic region is employed as a part of a subunit vaccine. As the sequence and the structure of the epitopic region are highly conserved in hexon proteins of adenoviruses, the epitopic region could be employed as a promising VLP vaccine candidate against adenoviral diseases, in general.
AB - Adenoviruses cause economically important diseases in vertebrates. Effective vaccines against adenoviral diseases are currently lacking. Here, we report a highly conserved epitopic region on hexon proteins of adenoviruses that generate a strong immune response when used as a virus-like-particle (VLP) vaccine, produced by inserting the epitopic region into the core protein of hepatitis B virus. For evaluation of its protective efficacy, the epitopic region from a representative adenovirus, fowl adenovirus serotype 4 (FAdV-4), was tested as a VLP vaccine which conferred 90% protection against challenge with a virulent FAdV-4 isolate in chickens. Importantly, such a high level of protection is not achieved when the epitopic region is employed as a part of a subunit vaccine. As the sequence and the structure of the epitopic region are highly conserved in hexon proteins of adenoviruses, the epitopic region could be employed as a promising VLP vaccine candidate against adenoviral diseases, in general.
U2 - 10.1016/j.vaccine.2021.05.023
DO - 10.1016/j.vaccine.2021.05.023
M3 - Journal article
C2 - 34030897
VL - 39
SP - 3560
EP - 3564
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 27
ER -
ID: 272115140